Nadia Waheed, Chief Medical Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 14,828 shares at $8.27 ($123K) on 2026-06-03, disclosed to the SEC on 2026-06-05.
Open-market sale of $123k OCUL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OCUL | SELL | 2025-06-03 | $223K | — | Filing → |